Drugs / MR-130A-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06672016 | Jan 2025 → May 2027 expected | — | Mylan Pharmaceuticals Inc | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MR-130A-01 | “MR-130A-01 transdermal system, patch to be used for female contraception” NCT06672016 ↗ |